tiprankstipranks

FSPHX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

FSPHX Analyst Rating

Strong Buy
73ConsensusRatings
68 Buy
5 Hold
0 Sell
Based on the consensus analyst ratings on 73 stocks held in FSPHX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FSPHX Analyst Price Target

Average Price Target

$36.66
Based on 73 Wall Street analysts offering 12 month price targets to Fidelity Select Health Care holdings in the last 3 months. The average price target is $36.66 with a high forecast of $43.67 and a low forecast of $29.95. The average price target represents a 20.76% change from the last price of $30.36.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","29":"$29","34":"$34","39":"$39","44":"$44"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43.667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$43.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$36.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.953,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$29.95</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,29,34,39,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.8,29.943615384615384,31.08723076923077,32.23084615384616,33.37446153846154,34.518076923076926,35.661692307692306,36.80530769230769,37.94892307692308,39.09253846153847,40.23615384615385,41.379769230769234,42.523384615384614,{"y":43.667,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.8,29.404923076923076,30.009846153846155,30.61476923076923,31.21969230769231,31.824615384615385,32.42953846153846,33.03446153846154,33.639384615384614,34.24430769230769,34.84923076923077,35.45415384615385,36.05907692307692,{"y":36.664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.8,28.88869230769231,28.977384615384615,29.066076923076924,29.15476923076923,29.24346153846154,29.332153846153847,29.420846153846153,29.50953846153846,29.59823076923077,29.686923076923076,29.775615384615385,29.86430769230769,{"y":29.953,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":28.2,"date":1688342400000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.42,"date":1690848000000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.97,"date":1693526400000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.4,"date":1696204800000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.21,"date":1698796800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.69,"date":1701388800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.02,"date":1704153600000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.49,"date":1706745600000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.62,"date":1709251200000,"info":"<div>Price: <b>$31<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.45,"date":1711929600000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.35,"date":1714521600000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.48,"date":1717372800000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.8,"date":1719792000000,"info":"<div>Price: <b>$29<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$43.67Average Price Target$36.66Lowest Price Target$29.95
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FSPHX Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
ACELYRIN, INC.
4 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Acumen Pharmaceuticals, Inc.
3 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Poseida Therapeutics, Inc.
4 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Allogene Therapeutics
10 Buy
2 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Zentalis Pharmaceuticals Inc
4 Buy
5 Hold
1 Sell
Moderate Buy

FSPHX Stocks With Highest Downside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Alignment Healthcare, Inc.
6 Buy
2 Hold
1 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Agilon Health Inc
5 Buy
9 Hold
1 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Humana
8 Buy
7 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Morphic Holding
2 Buy
7 Hold
0 Sell
Hold
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Glaukos Corp.
8 Buy
3 Hold
0 Sell
Moderate Buy

FSPHX Mutual Fund FAQ

What is FSPHX’s average 12-month price target, according to analysts?
Based on analyst ratings, Fidelity Select Health Care’s 12-month average price target is $36.66.
    What is FSPHX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for FSPHX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is FSPHX a Buy, Sell or Hold?
        Fidelity Select Health Care has a consensus rating of Strong Buy which is based on 68 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Fidelity Select Health Care’s price target?
          The average price target for Fidelity Select Health Care is $36.66. This is based on 73 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $43.67 ,the lowest forecast is $29.95. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Fidelity Select Health Care?
            Fidelity Select Health Care’s analyst rating consensus is a Strong Buy. This is based on the ratings of 73 Wall Streets Analysts.
              How can I buy shares of FSPHX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis